Raport bieżący nr 5/2019
Art. 17 ust. 1 MAR - informacje poufne.
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today announced it received the signed distribution agreement with RedOne Medical, a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and Department of Defense (DoD) hospitals, to distribute the CompuFlo® Epidural System.
RedOne Medical is a CVE-certified Service-Disabled Veteran-Owned Small Business (SDVOSB) located in Savannah, GA. Wholly owned and operated by a combat veteran, RedOne Medical is a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and Department of Defense (DoD) hospitals. RedOne Medical donates a portion of profits to leading charities as part of its mission to support veterans, military families and their communities.
The Board of Directors of the Issuer believes that partnering with RedOne Medical will provide the access to all federal medical facilities worldwide and is one of many strategic initiatives in order to support the global rollout strategy of the CompuFlo® Epidural System. The Board of Directors of the Company is excited to partner with RedOne Medical to improve healthcare outcomes for America's warfighter and veteran patients. The Board of Directors of the Issuer is honored to support VA and DoD hospitals with its clinically proven CompuFlo® Epidural System, which is 99% effective in identifying the epidural space on the first attempt, 14% more successful in patients with high body mass index, and reduces procedure time by one minute.
The recent results of international multicenter study, that were announced at the ANESTHESIOLOGY® 2019 Annual Meeting in Orlando, Florida compared the accidental dural puncture rate and its complications while using the CompuFlo® Epidural System versus traditional loss of resistance (LOR) technique in patients under labor epidural analgesia. The study collected records between 2015 and 2019 of epidural administration on labor and delivery patients using the CompuFlo® Epidural System from four institutions, one in the U.S., one in Chile, and two from Italy. Among the four sites, there were 812 patients who received epidural analgesia with CompuFlo® and none had accidental dural puncture regardless of the composition of the epidural performer types. In comparison, the rate of accidental dural puncture was 5% in the LOR group in the non inferiority trial.
|PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ|
|Data||Imię i Nazwisko||Stanowisko/Funkcja||Podpis|
|2019-12-13||Joseph D'Agostino||Chief Financial Officer||Joseph D'Agostino|